| Miriam Olga Anolik, MD | |
|
25 Bala Ave Ste 102, Bala Cynwyd, PA 19004-3214 | |
| (215) 452-0304 | |
| (215) 452-0311 |
| Full Name | Miriam Olga Anolik |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 25 Bala Ave Ste 102, Bala Cynwyd, Pennsylvania |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366524043 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | MD019870E (Pennsylvania) | Primary |
| Entity Name | Philadelphia Health Associates-pediatrics, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770547499 PECOS PAC ID: 1658556105 Enrollment ID: O20110426000793 |
News Archive
For a highly variable disease like cystic fibrosis, personalized medicine promises treatments based on individual factors, down to the molecular level. This promise is especially alluring for the treatment of children with cystic fibrosis, who are at particular risk for complications that could affect them throughout their lives.
The research just published by a group of scientists from the Centre for Genomic Regulation (CRG) in Barcelona, Spain, led by Eulàlia Martí, in cooperation with researchers from the University of Barcelona (UB) and August Pi i Sunyer Biomedical Research Institute (IDIBAPS), has brought to light new information on the molecular mechanisms that cause Huntington's disease, and defines new pathways to therapy discovery.
Meda has signed a long-term license agreement with the specialty division of Mylan Inc., Dey Pharma, L.P., for exclusive marketing and distribution rights of EpiPen® (epinephrine) Auto-Injector in Europe. EpiPen is used for emergency treatment of severe allergic reactions (anaphylaxis). Anaphylaxis can occur quickly (often within a couple of minutes) and may be life-threatening.
Arthritis and other inflammatory conditions could be helped by new insights into how the immune response is switched off.
The U.S. opioid epidemic has evolved so much in the last four years that current federal policy responses risk diminishing returns in saving human lives, according to a new peer-reviewed perspective by University of Alabama at Birmingham Associate Professor of Preventive medicine Stefan Kertesz, M.D. His perspective was published online in the addiction journal Substance Abuse.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Miriam Olga Anolik, MD 25 Bala Ave Ste 102, Bala Cynwyd, PA 19004-3214 Ph: (215) 452-0304 | Miriam Olga Anolik, MD 25 Bala Ave Ste 102, Bala Cynwyd, PA 19004-3214 Ph: (215) 452-0304 |
News Archive
For a highly variable disease like cystic fibrosis, personalized medicine promises treatments based on individual factors, down to the molecular level. This promise is especially alluring for the treatment of children with cystic fibrosis, who are at particular risk for complications that could affect them throughout their lives.
The research just published by a group of scientists from the Centre for Genomic Regulation (CRG) in Barcelona, Spain, led by Eulàlia Martí, in cooperation with researchers from the University of Barcelona (UB) and August Pi i Sunyer Biomedical Research Institute (IDIBAPS), has brought to light new information on the molecular mechanisms that cause Huntington's disease, and defines new pathways to therapy discovery.
Meda has signed a long-term license agreement with the specialty division of Mylan Inc., Dey Pharma, L.P., for exclusive marketing and distribution rights of EpiPen® (epinephrine) Auto-Injector in Europe. EpiPen is used for emergency treatment of severe allergic reactions (anaphylaxis). Anaphylaxis can occur quickly (often within a couple of minutes) and may be life-threatening.
Arthritis and other inflammatory conditions could be helped by new insights into how the immune response is switched off.
The U.S. opioid epidemic has evolved so much in the last four years that current federal policy responses risk diminishing returns in saving human lives, according to a new peer-reviewed perspective by University of Alabama at Birmingham Associate Professor of Preventive medicine Stefan Kertesz, M.D. His perspective was published online in the addiction journal Substance Abuse.
› Verified 1 days ago
Dr. Nancy Hillis, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 25 Bala Avenue, Suite 102, Bala Cynwyd, PA 19004 Phone: 215-452-0304 Fax: 215-452-0311 | |
Dr. Adrian Dana, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 191 Presidential Blvd, Unit 730, Bala Cynwyd, PA 19004 Phone: 610-256-0982 |